Synthesis and Evaluation of ePSMA-DM1: A New Theranostic Small-Molecule Drug Conjugate (T-SMDC) for Prostate Cancer.

Murce, Erika; Spaan, Evelien; Beekman, Savanne; van den Brink, Lilian; Handula, Maryana; Stuurman, Debra; de Ridder, Corrina; Dalm, Simone U; Seimbille, Yann

Murce, Erika; Spaan, Evelien; Beekman, Savanne; van den Brink, Lilian; Handula, Maryana; Stuurman, Debra; de Ridder, Corrina; Dalm, Simone U; Seimbille, Yann.

Afiliación

Murce E; Department of Radiology and Nuclear Medicine, University Medical Center Rotterdam, Erasmus MC, 3015 GD Rotterdam, The Netherlands.
Spaan E; Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Beekman S; Department of Radiology and Nuclear Medicine, University Medical Center Rotterdam, Erasmus MC, 3015 GD Rotterdam, The Netherlands.
van den Brink L; Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Handula M; Department of Radiology and Nuclear Medicine, University Medical Center Rotterdam, Erasmus MC, 3015 GD Rotterdam, The Netherlands.
Stuurman D; Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
de Ridder C; Department of Radiology and Nuclear Medicine, University Medical Center Rotterdam, Erasmus MC, 3015 GD Rotterdam, The Netherlands.
Dalm SU; Erasmus MC Cancer Institute, 3015 GD Rotterdam, The Netherlands.
Seimbille Y; Department of Radiology and Nuclear Medicine, University Medical Center Rotterdam, Erasmus MC, 3015 GD Rotterdam, The Netherlands.

Pharmaceuticals (Basel) ; 16(8)2023 Jul 28.

Article en En | MEDLINE | ID: mdl-37630990

Palabras clave

DM1; PSMA; SPECT/CT imaging; prostate cancer; small-molecule drug conjugate; targeted therapy; theranostics

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceuticals (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google